European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- Hot! -

Primarily intended for oral administration, though they can be swallowed whole, chewed, or dispersed in water.

| Test Category | Key Tests and Requirements | | :--- | :--- | | | A test to confirm the identity of the active substance(s) in the tablet, usually by a technique like chromatography or spectroscopy. | | Dissolution/Disintegration | For rapidly dissolving products, a disintegration test may suffice; otherwise, a dissolution test is required. Unless otherwise justified, a suitable dissolution test, such as one described in Ph. Eur. general chapter 2.9.3 , must be carried out. | | Uniformity of Dosage Units | This ensures the dosage form contains the correct amount of drug substance. The harmonised chapter 2.9.40 is the binding requirement for intact tablets, while monograph 0478 provides additional rules for scored tablets. | | Friability | This test (Chapter 2.9.7 ) measures the tendency of tablets to chip or break during handling and transport. | | Resistance to Crushing | This test (Chapter 2.9.8 ) measures the mechanical strength of tablets, ensuring they are hard enough to withstand processing but not too hard to prevent disintegration. | | Microbiological Quality | Tablets must comply with the limits for total microbial count and the absence of specified pathogens as per Chapter 5.1.4 . |

: Formulations meant to be dissolved or smoothly dispersed in water prior to ingestion. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

The Ph. Eur. monograph for Tablets - 0478 is a comprehensive guide that sets standards for the quality of tablets. By following the guidelines set out in the monograph, manufacturers can ensure that their tablets meet the required standards for quality, purity, and strength. The monograph plays a crucial role in ensuring patient safety, increasing confidence in the quality of medicines, and facilitating market authorization. As the pharmaceutical industry continues to evolve, the Ph. Eur. monograph for Tablets - 0478 remains an essential resource for ensuring the quality of tablet formulations.

In the complex world of pharmaceutical manufacturing, consistency isn't just a goal—it's a legal requirement. For anyone operating within the 39 member states of the European Pharmacopoeia Convention European Pharmacopoeia (Ph. Eur.) Monograph 0478 Primarily intended for oral administration, though they can

: Tablets that disperse rapidly in the mouth before swallowing.

Designed to melt in the mouth without the need for water. | | Uniformity of Dosage Units | This

However, the monograph does not apply in isolation. It must be read in conjunction with the general chapters of the Ph. Eur., particularly the and the General Chapter on Uniformity of Dosage Units (2.9.40) . This hierarchical structure ensures consistency across all monographs while allowing specific tests tailored to tablets.

The European Pharmacopoeia (Ph. Eur.) Monograph 0478 ( ) defines mandatory quality standards, including tests for uniformity, disintegration, and dissolution, to ensure the safety and efficacy of tablets intended for oral administration. Covering various forms, from conventional to modified-release, it mandates specific, rigorous quality control tests to ensure compliance. For a detailed overview, review the ECA Academy article on the topic.